or Try an Advanced Search...

    Technical Analysis for SONN - SONNET BioTherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.79 -1.10% -0.02
    SONN closed down 1.1 percent on Wednesday, May 15, 2024, on 7 percent of normal volume. It ran into resistance at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SONN trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Fell Below 20 DMA Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Spinning Top Other 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Earnings Movers Other 0.00%
    Outside Day Range Expansion 0.00%
    50 DMA Resistance Bearish -1.10%
    20 DMA Support Bullish -1.10%
    MACD Bullish Signal Line Cross Bullish -1.10%
    Older End-of-Day Signals for SONN ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 15 hours ago
    Fell Below 20 DMA about 15 hours ago
    20 DMA Support about 20 hours ago
    10 DMA Support about 20 hours ago
    Rose Above Previous Day's High about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SONN Chart by TradingView
    Basic chart:

    Profile

    SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Biology Immunology Antibody Cytokine Blood Plasma Biochemistry

    Is SONN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 6 Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
    Mar 11 Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
    Feb 29 Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
    Feb 14 Sonnet BioTherapeutics GAAP EPS of -$0.31, revenue of $18.63M
    Feb 14 Sonnet BioTherapeutics GAAP EPS of -$0.31
    Feb 14 Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
    Dec 22 Sonnet BioTherapeutics files for $100M mixed shelf
    Dec 21 Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
    See more SONN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.4
    52 Week Low 1.08
    Average Volume 101,238
    200-Day Moving Average 2.51
    50-Day Moving Average 1.89
    20-Day Moving Average 1.80
    10-Day Moving Average 1.81
    Average True Range 0.13
    RSI (14) 47.64
    ADX 12.44
    +DI 18.08
    -DI 22.06
    Chandelier Exit (Long, 3 ATRs) 1.58
    Chandelier Exit (Short, 3 ATRs) 2.04
    Upper Bollinger Bands 1.90
    Lower Bollinger Band 1.69
    Percent B (%b) 0.46
    BandWidth 11.76
    MACD Line -0.02
    MACD Signal Line -0.02
    MACD Histogram 0.0013
    Fundamentals Value
    Market Cap 5.49 Million
    Num Shares 3.07 Million
    EPS -18.14
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 29.80
    Price-to-Book 19.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.06
    Resistance 3 (R3) 2.07 1.98 2.02
    Resistance 2 (R2) 1.98 1.91 1.98 2.00
    Resistance 1 (R1) 1.89 1.87 1.85 1.88 1.99
    Pivot Point 1.80 1.80 1.78 1.80 1.80
    Support 1 (S1) 1.71 1.73 1.66 1.70 1.59
    Support 2 (S2) 1.62 1.69 1.62 1.58
    Support 3 (S3) 1.53 1.62 1.56
    Support 4 (S4) 1.52